Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 08/30 06:51:30 pm
73.46 USD   +0.47%
04:56a Prime Therapeutics, Walgreens to form pharmacy alliance
04:40a PFIZER : St. Louis area manufacturer of EpiPens to produce Mylan's n..
08/29DJWalgreens Forms Alliance With Prime Therapeutics
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Express Scripts Holding Co : Express Scripts Sues Ernst & Young Alleging Document Theft

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/16/2013 | 12:36am CEST
   By Jon Kamp and Michael Rapoport 
 

Pharmacy-benefit giant Express Scripts Holding Co. (ESRX) has filed a lawsuit against accounting firm Ernst & Young LLP and a former employee for allegedly stealing at least 20,000 pages of data containing confidential information and trade secrets.

St. Louis-based Express Scripts hired E&Y to provide consulting services while combining its business with Medco Health Solutions. Express Scripts bought Medco last year to form the largest pharmacy-benefit manager by prescriptions handled.

These firms, known as PBMs, managed drug benefits for health plans and corporate clients, using their buying clout to secure rebates from drug manufacturers. Express Scripts said in the lawsuit that its investigation did not show E&Y's actions affecting any patient or protected health information.

But Express Scripts did accuse the big-four accounting giant of taking "competitively sensitive cost and pricing information" and "highly proprietary" documents involving business and integration strategies, projections and performance metrics.

Express Scripts didn't have a comment on the matter beyond the content of the court filing, which seeks "substantial punitive damages," and to stop E&Y from using or disclosing the information at issue. The lawsuit was filed Thursday in the Circuit Court in St. Louis County, Mo., and reviewed by Dow Jones Newswires.

E&Y in a statement Friday confirmed there was a violation of company policies, and that the individual "at the center of these allegations"--who the Express Scripts lawsuit said was a Health Care IT Partner named Donald Gravlin--"is no longer with the firm."

But E&Y also said it will "vigorously contest the claims" in the lawsuit. The accounting firm noted it "immediately took all necessary steps" to secure the data at issue once it became aware of the matter, and that it's not aware of any instance where the data was used inappropriately or transmitted to a third party.

According to Express Scripts' allegations, an investigation launched last August determined Mr. Gravlin was sending confidential information from another E&Y employee's Express Scripts email account to an outside email account. The company accused him of "sneaking into Express Scripts' headquarters and stealing confidential and proprietary information" for months.

The PBM also alleged that E&Y was motivated to facilitate this activity because it stood to gain from the confidential information, which could be used to grow and develop additional business both with Express Scripts and competitors.

Attempts to reach Mr. Gravlin late Friday were unsuccessful.

E&Y said it believes its prompt action to secure the data prevented any harm to Express Scripts. "Ernst & Young takes client confidentiality seriously," the company said. "We are fully committed to following our clients' security protocols."

Express Scripts uses PricewaterhouseCoopers for auditing work and Deloitte for tax accounting.

Write to Jon Kamp at jon.kamp@dowjones.com

Corrections & Amplifications

This was corrected at 7:47 p.m. EST because the original incorrectly identified the accounting firm in the last paragraph as PricewaterhouseCoopers. That firm does auditing work for Express Scripts, and the tax accountant is Deloitte.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
04:56a Prime Therapeutics, Walgreens to form pharmacy alliance
04:40a PFIZER : St. Louis area manufacturer of EpiPens to produce Mylan's new generic v..
08/29DJWalgreens Forms Alliance With Prime Therapeutics
08/25 NASDAQ 100 MOVERS : Dltr, mu
08/24 LAWSUIT FOR LONG-TERM INVESTORS IN S : ESRX) Filed
08/18 EXPRESS SCRIPTS : Will your prescriptions be covered in 2017?
08/17 EXPRESS SCRIPTS : to fund $175,000 for Christian Hospital's CHAP partnership wit..
08/13 EXPRESS SCRIPTS : A secretive board controls access to prescription drugs for mi..
08/10 RITE AID : Toms River man battles Rite Aid for refund
08/03 NOVO NORDISK A/S : Diabetes drug shunned by Express Scripts Business briefing
More news
Sector news : Drug Retailers - NEC
08:49aDJFirms Drop Prettied-Up Results -- WSJ
08/29DJWALGREENS BOOTS ALLIANCE : Forms Alliance With Prime Therapeutics -- Update
08/29DJCompanies Play Up Standard Accounting Figures
08/29DJWALGREENS BOOTS ALLIANCE : Forms Alliance With Prime Therapeutics
08/29DJWalgreens Forms Alliance With Prime Therapeutics
More sector news : Drug Retailers - NEC
News from SeekingAlpha
08/29 UnitedHealth Is A Strong Buy
08/29 Hate The Game, Not The Player? - Mylan Is Out Of Tune Amid An Angry Chorus
08/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2016 Updat..
08/23 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2016 Upda..
08/12 DIPLOMAT PHARMACY : The Correction Seems Overdone, Overlooking The Performance
Advertisement
Financials ($)
Sales 2016 101 827 M
EBIT 2016 6 532 M
Net income 2016 2 912 M
Debt 2016 12 635 M
Yield 2016 -
P/E ratio 2016 15,95
P/E ratio 2017 14,46
EV / Sales 2016 0,58x
EV / Sales 2017 0,54x
Capitalization 46 082 M
More Financials
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 82,1 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..-16.35%46 082
CVS HEALTH CORP-4.80%99 243
WALGREENS BOOTS ALLIAN..-5.64%86 964
MCKESSON CORPORATION-6.76%41 507
CARDINAL HEALTH INC-10.64%25 414
AMERISOURCEBERGEN CORP..-16.78%20 532
More Results